SCHEMBL4540057

SCHEMBL4540057

Cn1cnc(-c2ccc(Cl)c(Cl)c2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2E1 P05181 1/20 0.49
CYP2A6 P11509 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2B6 P20813 1/20 0.49
CYP2C19 P33261 1/20 0.49
KMO O15229 7/20 0.47
AHR P35869 2/20 0.46
FTO Q9C0B1 1/20 0.46
NPC1 O15118 2/20 0.45
ALDH1A1 P00352 2/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16606147 0.78 CYP2E1 (0.49) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL23539461 0.76 CYP2E1 (0.56) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL30042352 0.76 CYP2E1 (0.56) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL28294098 0.76 SIGMAR1 (0.40) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL19957258 0.76 CYP2E1 (0.44) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL18806853 0.75 CYP2C9 (0.57) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL8250569 0.75 LRRK2 (0.59) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL10985144 0.73 CYP2E1 (0.51) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL12427197 0.73 CYP2E1 (0.51) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL13780328 0.73 CYP2E1 (0.51) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108614-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES HYDRA BIOSCIENCES, INC. 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108614-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES ELANE, CASP3, MMP8 CYP2E1 326/4885CYP2A6 2170/4885CYP2C9 1093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.